These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1944011)

  • 1. LHRH-induced gonadotropin release before and after short-term therapy with cabergoline in hyperprolactinaemic patients.
    Durante R; Giusti M; Carraro A; Porcella E
    Minerva Endocrinol; 1991; 16(1):11-6. PubMed ID: 1944011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of subacute cabergoline treatment on prolactin, thyroid stimulating hormone and growth hormone response to simultaneous administration of thyrotrophin-releasing hormone and growth hormone-releasing hormone in hyperprolactinaemic women.
    Giusti M; Lomeo A; Torre R; Sghedoni D; Mazzocchi G; Durante R; Giordano G
    Clin Endocrinol (Oxf); 1989 Mar; 30(3):315-21. PubMed ID: 2574083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study.
    Nachtigall LB; Valassi E; Lo J; McCarty D; Passeri J; Biller BM; Miller KK; Utz A; Grinspoon S; Lawson EA; Klibanski A
    Clin Endocrinol (Oxf); 2010 Jan; 72(1):53-8. PubMed ID: 19508591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
    Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
    Nicoletti I; Ambrosi F; Giammartino C; Fedeli L; Mannarelli C; Filipponi P
    Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia.
    Colao A; Di Sarno A; Cappabianca P; Di Somma C; Pivonello R; Lombardi G
    N Engl J Med; 2003 Nov; 349(21):2023-33. PubMed ID: 14627787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of methergoline on impulse secretion of gonadotropins in women with hyperprolactinemic ovarian insufficiency].
    Potin VV; Svechnikova FA; Soboleva EL
    Akush Ginekol (Mosk); 1989 Jul; (7):16-9. PubMed ID: 2802060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of metergoline on prolactin, follicle stimulating hormone, luteinizing hormone and thyroid stimulating hormone response to TRH and LHRH in normal men and women.
    Sartani A; de Pasqua A; Cesati R; Farina L; Pontiroli AE
    Horm Metab Res; 1984 Oct; 16(10):535-8. PubMed ID: 6437954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of sex-hormone-binding globulin and free sex steroid hormones in hyperandrogenic anovulation.
    Ohsawa M; Asai M; Masahashi T; Narita O; Tomoda Y; Matsui N
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2081-8. PubMed ID: 2947958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary response to LHRH in hypothyroid women.
    Drake TS; O'Brien WF; Tredway DR
    Obstet Gynecol; 1980 Oct; 56(4):488-91. PubMed ID: 6775259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropic responsiveness to clomiphene, LRH, estradiol, and bromocriptine in galactorrheic women.
    Forsbach G; Soria J; Canales ES; Guzman V; Cabezas A; Zárate A
    Obstet Gynecol; 1977 Aug; 50(2):139-44. PubMed ID: 327363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of serum PRL bioactivity evaluation in hyperprolactinaemic women with different menstrual disorders.
    Kostrzak A; Warenik-Szymankiewicz A; Meczekalski B
    Gynecol Endocrinol; 2009 Dec; 25(12):799-806. PubMed ID: 19905999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cabergoline: long-acting oral treatment of hyperprolactinemic disorders.
    Ferrari C; Mattei A; Melis GB; Paracchi A; Muratori M; Faglia G; Sghedoni D; Crosignani PG
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1201-6. PubMed ID: 2656736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery pattern of hypothalamo-pituitary-testicular axis in patients with macroprolactinomas after treatment with cabergoline.
    Walia R; Bhansali A; Dutta P; Khandelwal N; Sialy R; Bhadada S
    Indian J Med Res; 2011 Sep; 134(3):314-9. PubMed ID: 21985814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotic-range proteinuria in a patient with a giant prolactinoma.
    Heras M; Iglesias P; Fernández-Reyes MJ; Sánchez R; Jiménez MJ; Muñoz H; Tajada P; Duarte J
    Am J Kidney Dis; 2008 Jun; 51(6):1025-8. PubMed ID: 18455849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy.
    Ciccarelli E; Grottoli S; Razzore P; Gaia D; Bertagna A; Cirillo S; Cammarota T; Camanni M; Camanni F
    J Endocrinol Invest; 1997 Oct; 20(9):547-51. PubMed ID: 9413809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary responsiveness to LHRH and TRH in adolescent girls.
    Lemarchand-Béraud T; Zufferey M; Reymond M; Rey-Stocker I
    Bull Schweiz Akad Med Wiss; 1978 Mar; 34(1-3):241-54. PubMed ID: 96896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopenia in children and adolescents with hyperprolactinemia.
    Galli-Tsinopoulou A; Nousia-Arvanitakis S; Mitsiakos G; Karamouzis M; Dimitriadis A
    J Pediatr Endocrinol Metab; 2000 Apr; 13(4):439-41. PubMed ID: 10777000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women.
    Lebbe M; Hubinont C; Bernard P; Maiter D
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):236-42. PubMed ID: 20455894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary and testicular response to luteinizing hormone releasing hormone in normal and sulpiride-induced hyperprolactinaemic men.
    Nakano R; Yagi S; Nishi T
    Exp Clin Endocrinol; 1988 May; 91(2):191-6. PubMed ID: 3137082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.